Breakthrough in brain tumour research

June 28, 2016, University of Portsmouth
Breakthrough in brain tumour research
Glioblastoma, one of the most aggressive forms of brain tumour, which kills thousands of patients within a year. Credit: Alison Howarth, therapeutics team at the Brain Tumour Research’s centre of excellence, University of Portsmouth

A potentially ground-breaking scientific breakthrough with far-reaching consequences for future treatments of brain tumours is to be revealed at an international research meeting in Poland today.

Professor Geoff Pilkington and Dr Richard Hill, from the Brain Tumour Research Centre of Excellence at the University of Portsmouth, will present their research findings at the conference "Brain Tumours 2016 – From Biology to Therapy".  Their group has been collaborating with Innovate Pharmaceuticals who have developed a novel formulation "IP1867B", combining reformulated aspirin with two additional ingredients, into a soluble form.  Developing a true liquid aspirin has long been a scientific goal, as "soluble" aspirins currently on the market are not completely soluble and still contain grains that cause gastric side effects.

Most significantly for patients with brain tumours, this new formulation significantly increases the ability of drugs to cross the blood brain barrier.  This membrane serves to protect the brain but also blocks many conventional cancer drugs from reaching brain tumours.  This research suggests that Innovate Pharmaceutical's IP1867B could be highly effective against glioblastoma (GBM), one of the most aggressive forms of the disease, which kills thousands of patients within a year.

The breakthrough came in laboratory tests on cancer cells from adults and children with brain tumours. In all the variations of drugs tested, including separating out the three key components of IP1867B, it was ten times more effective than any combination of other currently used drugs.

All three ingredients, which are already approved for use in the clinic, have been shown to kill tumour cells without having an effect on normal brain cells.  Although the drug will now be further developed in pre-clinical models, more research will be needed before we know whether it will be suitable for patients in clinical trials.

Sue Farrington Smith, Chief Executive of Brain Tumour Research, said: "This is a potential game-changer for research into tumours and clearly shows what sustainable research is able to achieve.  It is science like this that will enable us to eventually find a cure for this devastating disease which kills more children and adults under the age of 40 than any other cancer."

Explore further: 3D printing brain tumours to improve treatment

Related Stories

3D printing brain tumours to improve treatment

May 25, 2016
Scientists at a Heriot-Watt University plan to 3D print tumour-like constructs to better understand the biology of malignant brain tumours that kill around 5,000 people each year in the UK.

Scientists working to develop new brain tumour vaccine

June 6, 2016
Scientists have embarked on a new study aimed at developing a vaccine to target the most deadly form of brain tumour.

Scientists discover how to better map brain tumors

November 3, 2015
Scientists have discovered a protein that helps map the edge of brain tumours more clearly so they show up on magnetic resonance imaging (MRI) scans, according to new research presented at the National Cancer Research Institute ...

Cancer cells take up nanoparticles more rapidly than normal brain cells

December 17, 2015
New research carried out by drug delivery experts at The University of Nottingham has highlighted more advantages to using nanoparticles for the delivery of cancer drugs.

Vitamin E a potential biomarker for development of brain tumors

May 19, 2016
Researchers at Umeå University in Sweden and the Cancer Registry of Norway have studied possible causes behind the development of brain tumours. The results, published in the journal Oncotarget, show differences in expression ...

Scientists identify link between brain development and cancer

April 20, 2016
Researchers at The University of Queensland and the QIMR Berghofer Medical Research Institute have identified a protein which plays a key role in brain cancer, opening the door to potential new treatments.

Recommended for you

Function of neutrophils during tumor progression unraveled

October 15, 2018
Researchers at The Wistar Institute have characterized the function of neutrophils, a type of white blood cells, during early stages of tumor progression, showing that they migrate from the bone marrow to distant sites and ...

Delving where few others have gone, leukemia researchers open new path

October 15, 2018
A Wilmot Cancer Institute study uncovers how a single gene could be at fault in acute myeloid leukemia (AML), one of the deadliest cancers. The breakthrough gives researchers renewed hope that a gene-targeted therapy could ...

3-D mammography detected 34% more breast cancers in screening

October 15, 2018
In traditional mammography screening, all breast tissue is captured in a single image. Breast tomosynthesis, on the other hand, is three-dimensional and works according to the same principle as what is known as tomography. ...

More clues revealed in link between normal breast changes and invasive breast cancer

October 15, 2018
A research team, led by investigators from Georgetown Lombardi Comprehensive Cancer Center, details how a natural and dramatic process—changes in mammary glands to accommodate breastfeeding—uses a molecular process believed ...

Cancer stem cells use 'normal' genes in abnormal ways

October 12, 2018
CDK1 is a "normal" protein—its presence drives cells through the cycle of replication. And MHC Class I molecules are "normal" as well—they present bits of proteins on the surfaces of cells for examination by the immune ...

Obesity linked to increased risk of early-onset colorectal cancer

October 12, 2018
Women who are overweight or obese have up to twice the risk of developing colorectal cancer before age 50 as women who have what is considered a normal body mass index (BMI), according to new research led by Washington University ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.